Medicare hands AI device makers a 5-year pricing blank check

What it does

This bill amends Medicare's payment rules to create a special fast-track payment category for AI-powered medical devices and software. Manufacturers can submit their own cost data to set initial payment rates, and Medicare cannot reclassify these services for at least 5 years—even if actual claims data later shows the rates are too high. The bill also codifies a policy allowing hospitals to bill Medicare separately for AI software used alongside other services.

Why we flagged it

The bill's operative mechanism is a guaranteed payment floor for AI medical devices, set by manufacturer cost submissions, with a 5-year lock-in preventing Medicare from adjusting rates downward based on actual claims experience. This is a direct subsidy to the AI healthcare technology sector, disguised as a 'payment appropriateness' measure.

• Subsection (b) codifies a separate billing policy for software-as-a-service, allowing hospitals to bill Medicare separately for AI software used with other services—unrelated to the main algorithm-based healthcare services classification.

What the text implies

• Manufacturers can embed inflated costs (overhead, subscription fees, clinical staff) into their initial submissions, and Medicare cannot challenge or adjust downward for 5 years, creating a permanent cost floor.
• The 5-year lock-in prevents Medicare from using real-world claims data to reassess whether payment rates match actual service delivery costs, breaking the normal feedback loop that controls healthcare inflation.
• The definition of 'algorithm-based healthcare service' is extremely broad and delegated to the Secretary, allowing expansion to services that are 'adjunctive to' or 'performed concurrently with' other services—potentially capturing routine clinical workflows as billable AI services.
• Hospitals can now bill separately for AI software used alongside existing services, fragmenting billing and making it harder for Medicare to track total costs per patient encounter.
• The bill's title ('ensure appropriate payment') masks a mechanism that guarantees payment based on manufacturer cost claims, not independent appropriateness review.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Medicare beneficiaries and taxpayers face higher costs because payment rates are set by manufacturer submissions rather than independent cost analysis, and the 5-year lock-in prevents rate correction even if claims data reveals overpayment. The bill shifts pricing power from Medicare to device makers and creates a subsidy for AI healthcare technology adoption.

Who stands to gain

• AI healthcare device manufacturers
• medical software companies
• hospital outpatient departments (via separate billing for software)
• healthcare IT vendors

Named in the bill

Centers for Medicare & Medicaid Services (CMS), Food and Drug Administration (FDA), Department of Health and Human Services (HHS), Medicare, Hospital Outpatient Prospective Payment System (OPPS), ambulatory payment classification (APC)

Where it stands

4 cosponsors: 2 Democrats, 2 Republicans.

• Apr 9, 2025 — Introduced · Congress.gov: “Introduced in Senate”
• Apr 9, 2025 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

14 lobbying clients named this bill on 23 disclosure filings across 3 quarters, Dec 2025 to Jun 2026. Those filings disclosed $9,423,433 in lobbying spend. A filing names 9 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 94% of bills with at least one filing.

Mike Rounds, the sponsor, reported $1,681,790 in PAC receipts in the 2026 cycle. $5,000 of that came from 3 PACs tied to these lobbying clients.

• Philips Holding USA Inc. — $1,950,000 on 3 filings
• Advanced Medical Technology Assn — $1,913,000 on 2 filings
• Johnson & Johnson Services Inc — $1,440,000 on 1 filing
• Medtronic Inc — $1,180,000 on 1 filing
• Siemens Medical Solutions Usa, Inc — $860,000 on 1 filing

Lobbying Disclosure Act filings through Jul 21, 2026. A filing shows who paid to lobby on a bill it names, not what changed.